Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Treasury Shares (2016 - 2023)

BioRestorative Therapies (BRTX) has disclosed Treasury Shares for 6 consecutive years, with $48875.0 as the latest value for Q2 2016.

  • For the quarter ending Q2 2016, Treasury Shares rose 52.73% year-over-year to $48875.0, compared with a TTM value of $48875.0 through Jun 2016, up 52.73%, and an annual FY2015 reading of $32000.0, changed 0.0% over the prior year.
  • Treasury Shares was $97827.0 for Q4 2023 at BioRestorative Therapies, roughly flat from $97827.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.2 billion in Q1 2021 and bottomed at $97827.0 in Q1 2023.
  • Average Treasury Shares over 3 years is $195.8 million, with a median of $211194.5 recorded in 2022.
  • The sharpest move saw Treasury Shares changed 0.0% in 2012, then surged 52.73% in 2016.
  • Year by year, Treasury Shares stood at $32000.0 in 2012, then changed by 0.0% to $32000.0 in 2013, then changed by 0.0% to $32000.0 in 2014, then changed by 0.0% to $32000.0 in 2015, then soared by 52.73% to $48875.0 in 2016.
  • Business Quant data shows Treasury Shares for BRTX at $48875.0 in Q2 2016, $32000.0 in Q1 2016, and $32000.0 in Q4 2015.